Wellnex Life reports improved cash flow and revenue growth in second quarter
29 January, 2026
About Wellnex Life
Wellnex Life (ASX: WNX) is a specialist Australian brand and distribution company focused on the consumer health & wellness industry. The company has secured ranging and distribution agreements with major Australian retailers including Chemist Warehouse, Woolworths, Coles and CH2 and is growing its margins with the launch of a wholly-owned digital sales channel and shift to Wellnex-owned brands.
Access to SP Angel’s research via this website is subject to the following terms and conditions. SP Angel (‘SPA’) does not deal with individual or private investors (save in connection with corporate finance business). SPA’s research is thus not prepared for private investors and does not take into account any particular investor’s or class of investors’ investment objectives. You are therefore not being granted access to SPA research in your capacity as an investor or SPA client or potential investor or client. You understand that SPA is not offering you any financial service. Members of SPA’s Research department are not permitted to interact with private investors and you should not attempt to contact them.
8th April, 2022
Watch this 5-minute video to hear from CEO Michael Davidson to learn more about:
- How Prescienttherapeutics has accelerated its growth through partnerships with industry leaders Square, Stripe and Zip
- How the company’s pure tech approach and first-mover advantage is disrupting the SME finance market with more than 1.25 million potential customers
- How the company organically grew 420% since March 2021, hitting 30% quarter-on-quarter growth in March 2022, and its plans to continue growing exponentially
To stay up to date with Prescient Therapeutics or to receive alerts on company events, please register your details.
Our board
Board
Management
‹
Ash Vesali
Executive Chair
Ash Vesali
Executive Chair
A track record of guiding CXOs and boards through operational excellence, restructuring, and commercialisation. Bringing deep expertise in capital efficiency, revenue growth, market expansion across utilities, consumer, industrials, and technology sectors.Prior Forbes Technology Council member and speaker at several global forums on commercialisation and value creation.
Jeffrey Yeh
Non-Executive Director
Jeffrey Yeh
Non-Executive Director
Jeffrey Yeh is an experienced all-rounded entrepreneur, with over 21 years’ experience in all aspects of pharmaceutical sales, marketing, production, quality assurance, operations, logistics, finance and management. Jeffrey co-founded Homart Pharmaceuticals in 2002, and since then has grown Homart into a premier and award winning manufacturing and brand business with over 200 employees and an international presence.
Eric Jiang
Senior Independent
Non-Executive Director
Eric Jiang
Senior Independent
Non-Executive Director
Eric Jiang is a corporate adviser and independent board member. Eric brings a distinctive understanding of the cultural, economic and strategic context in which Australian businesses engage with China. Eric has previously sat on the boards of ASX listed corporates Connexion Media Limited (ASX:CXZ), Perpetual Resources Limited (ASX:PEC) and Wingara AG Limited (ASX:WNR). He is a past President of The Chinese Community Council of Australia.
›
‹
Eric Jiang
Senior Independent
Non-Executive Director
Eric Jiang
Senior Independent
Non-Executive Director
Eric Jiang is a corporate adviser and independent board member. Eric brings a distinctive understanding of the cultural, economic and strategic context in which Australian businesses engage with China. Eric has previously sat on the boards of ASX listed corporates Connexion Media Limited (ASX:CXZ), Perpetual Resources Limited (ASX:PEC) and Wingara AG Limited (ASX:WNR). He is a past President of The Chinese Community Council of Australia.
Jeffrey Yeh
Non-Executive Director
Jeffrey Yeh
Non-Executive Director
Jeffrey Yeh is an experienced all-rounded entrepreneur, with over 21 years’ experience in all aspects of pharmaceutical sales, marketing, production, quality assurance, operations, logistics, finance and management. Jeffrey co-founded Homart Pharmaceuticals in 2002, and since then has grown Homart into a premier and award winning manufacturing and brand business with over 200 employees and an international presence.
Ash Vesali
Executive Chair
Ash Vesali
Executive Chair
A track record of guiding CXOs and boards through operational excellence, restructuring, and commercialisation. Bringing deep expertise in capital efficiency, revenue growth, market expansion across utilities, consumer, industrials, and technology sectors.
Prior Forbes Technology Council member and speaker at several global forums on commercialisation and value creation.
›
Live investor Briefing
Wellnex Life (ASX: WNX)
Register for an Upcoming Webcast
Please join Wellnex Life Executive Chairman, Ash Vesali for an investor briefing.
In this session, Ash will explain:
- The outcomes of his cost cutting program.
- How he is driving revenue growth.
- Their focus for the next few quarters.
This should be an insightful session as Ash Vesali shares Wellnex’s financial turnaround and strategy to capture global market share.
This is a live and interactive online session, and participants are encouraged to ask questions. Spots are limited, so secure yours today.
Can’t make this time, register to receive the replay.
Attend the Session
What is a 708 investor?By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Corporate provide Corporate Advisory Services to Wellnex Life Limited and has been engaged by them to manage their investor communications including managing this offer and may receive fees for its services.
Register for an upcoming investor briefing with Wellnex Life to hear a company update and goals for the year.
